Mature results of a prospective study of deintensified chemoradiotherapy for low-risk human papillomavirus-associated oropharyngeal squamous cell carcinoma-Reference-Cited by-同舟云学术

Mature results of a prospective study of deintensified chemoradiotherapy for low-risk human papillomavirus-associated oropharyngeal squamous cell carcinoma

Published:2018-03-26 Issue:11 Volume:124 Page:2347-2354
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Chera Bhishamjit S.¹²^ORCID,Amdur Robert J.³⁴,Tepper Joel E.¹²,Tan Xianming²,Weiss Jared²⁵^ORCID,Grilley-Olson Juneko E.²⁵,Hayes D. Neil⁶,Zanation Adam⁷,Hackman Trevor G.⁷,Patel Samip⁷,Sheets Nathan⁸,Weissler Mark C.⁷,Mendenhall William M.³⁴^ORCID

Affiliation:

1. Department of Radiation Oncology; University of North Carolina School of Medicine; Chapel Hill North Carolina

2. UNC Lineberger Comprehensive Cancer Center; University of North Carolina Hospitals; Chapel Hill North Carolina

3. Department of Radiation Oncology; University of Florida Hospitals; Gainesville Florida

4. UF Health Shands Cancer Center; University of Florida Hospitals; Gainesville Florida

5. Division of Hematology Oncology, Department of Medicine; University of North Carolina School of Medicine; Chapel Hill North Carolina

6. Division of Hematology Oncology, Department of Medicine, University of Tennessee Health Science Center; Memphis Tennessee

7. Department of Otolaryngology/Head and Neck Surgery; University of North Carolina School of Medicine; Chapel Hill North Carolina

8. Rex UNC Healthcare; Raleigh North Carolina

Funder

University of North Carolina School of Medicine

Department of Radiation Oncology at the University of Florida School of Medicine

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference34 articles.

1. Human papillomavirus and survival of patients with oropharyngeal cancer;Ang;N Engl J Med.,2010

2. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis;Machtay;J Clin Oncol.,2008

3. Radiation Therapy Oncology Group Randomized phase II trial of transoral endoscopic head and neck surgery followed by risk-based IMRT and weekly cisplatin versus IMRT and weekly cisplatin for HPV negative oropharynx cancer http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=1221

4. ECOG-ACRIN Cancer Reserach Group Transoral surgery followed by low-dose or standard-dose radiation therapy with or without chemotherapy in treating patients with HPV positive stage III-IVA oropharyngeal cancer http://ecog-acrin.org/clinical-trials/e3311-educational-materials

5. E1308: reduced-dose IMRT in human papilloma virus (HPV)-associated resectable oropharyngeal squamous carcinomas (OPSCC) after clinical complete response (cCR) to induction chemotherapy (IC) [abstract];Cmelak;ASCO Meeting Abstracts.,2014

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Less is more: Exploring neoadjuvant immunotherapy as a de-escalation strategy in head and neck squamous cell carcinoma treatment;Cancer Letters;2024-08

2. A multicentric randomized controlled phase III trial of adaptive and 18F-FDG-PET-guided dose-redistribution in locally advanced head and neck squamous cell carcinoma (ARTFORCE);Radiotherapy and Oncology;2024-07

3. Biomarker Expression and Clinical Outcomes in International Study of Chemoradiation and Magnetic Resonance Imaging-Based Image-Guided Brachytherapy for Locally Advanced Cervical Cancer: BIOEMBRACE;International Journal of Radiation Oncology*Biology*Physics;2024-07

4. Crosstalk between CAFs and tumour cells in head and neck cancer;Cell Death Discovery;2024-06-26

5. HPV and head and neck cancer: A comprehensive review;Oral Oncology Reports;2024-06